UPDATE
: Wednesday, December 11, 2019
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
‘Novartis’ Kymriah takes one step closer to cancer cure’
by Lee Han-soo
2019-11-14 13:24
iCure to apply for testing incrementally modified cancer drugs in US
by Lee Han-soo
2019-11-13 17:35
JW Pharmaceutical launches joint-stock company in Vietnam
by Lee Han-soo
2019-11-13 16:52
‘Generic drugs must indicate ingredient names on label’
by Kim Yun-mi
2019-11-13 15:51
Daewoong releases trial results for autoimmune disease treatment in US
by Lee Han-soo
2019-11-12 14:09
라인
Hanmi to get ₩11.6 billion in royalty if FDA approves Rolontis
by Lee Han-soo
2019-11-11 18:02
Genexine’s new immunotherapy shows stability even in high dose
by Jeong Sae-im
2019-11-11 13:36
Medpacto releases trial results at US conference
by Lee Han-soo
2019-11-11 13:27
Yuhan, Cyclica to co-develop new drugs
by Lee Han-soo
2019-11-07 18:01
Takeda’s labor turmoil goes to extremes amid rumored unit sell-off
by Kim Yun-mi
2019-11-07 16:10
라인
‘One-third of heart attack survivors overlook risk of recurrence’
by Lee Han-soo
2019-11-06 16:34
AbbVie’s hepatitis C drug gets 8-week therapy regardless of cirrhosis
by Kim Yun-mi
2019-11-06 16:00
Crystal Genomics, Daehwa win patent for patch-form arthritis drug
by Lee Han-soo
2019-11-06 15:57
Dong-A ST's treatment of nail athlete's foot dominates local market
by Lee Han-soo
2019-11-06 14:09
Regulator to consider re-classifying choline alfoscerate as functional food
by Kim Yun-mi
2019-11-06 13:54
라인
Daewoong to sell Merck's cardiovascular disease treatment
by Lee Han-soo
2019-11-05 15:05
Merck Korea hurries to close GM part despite union’s protest
by Kim Yun-mi
2019-11-05 15:04
[Interview with global pharmas] 'Pfizer Korea combines Pfizer's outstanding innovation with Koreans’ talents'
by Lee Han-soo
2019-11-05 12:46
Yuhan, Dong-A, HanAll see Q3 earnings jump on licensing-out deals
by Jeong Sae-im
2019-11-04 15:52
Takeda Korea fires union leader to worsen labor-management dispute
by Kim Yun-mi
2019-11-04 15:03
-
1
2
3
4
5
6
7
8
9
10
다음
-
[Reporter's Notebook] Korean biopharmaceuticals have long way to go before reaching foreigners
SNUH finds new direct method to treat endometrial injury
SK Bioscience's chickenpox vaccine world's 2nd to get WHO’s PQ certification
‘There should be no Invossa fiasco again’
[Reporter's Notebook] Korean biopharmaceuticals have long way to go before reaching foreigners
SNUH finds new direct method to treat endometrial injury
SK Bioscience's chickenpox vaccine world's 2nd to get WHO’s PQ certification
‘There should be no Invossa fiasco again’
여백
Most viewed
1
Roche Diabetes Care stresses ‘integrated personalized diabetes management’
2
Gemvax & Kael unveils P2 trial result for Alzheimer treatment
3
Korea exports health insurance system to Bahrain
4
Syntekabio, CHA Hospital to co-develop immunotherapy
5
‘Endogenous T cells have high potential of treating blood, solid tumors’
6
AbbVie’s Venclexta nears insurance benefit
7
AMC unravels clues in treating relapsing, metastatic bladder cancer
8
‘Lynparza raises value of precision medicine as anticancer treatment’
9
Celltrion 1st Korean biopharmaceutical firm to achieve $1-billion exports
10
Korea selected as 'Medical Tourism Destination of the Year'
여백
Opinion
[Reporter's Notebook] Korean biopharmaceuticals have long way to go before reaching foreigners
[Column] Korea should do better in diabetes management
[Column] Digital healthcare for efficient distribution of medical resources
여백
Back to Top